UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028982
Receipt number R000033163
Scientific Title A confirmation study of the effect on human basal metabolism by consumption of the food which contains plant extract
Date of disclosure of the study information 2017/09/06
Last modified on 2020/10/06 09:57:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A confirmation study of the effect on human basal metabolism by consumption of the food which contains plant extract

Acronym

An effect study of plant extract on human basal metabolism

Scientific Title

A confirmation study of the effect on human basal metabolism by consumption of the food which contains plant extract

Scientific Title:Acronym

An effect study of plant extract on human basal metabolism

Region

Japan


Condition

Condition

Healthy male adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effect of consumption of the food that contains plant extract on human basal metabolism.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Basal metabolic rate

Key secondary outcomes

*Heart rate
*Deep body temperature
*Sleep situation


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Test food consumption, 5 weeks for efficiency evaluation, within 7 weeks for safety evaluation.-Washout 5 to 12 weeks-Control food consumption, 5 weeks for efficiency evaluation, within 7 weeks for safety evaluation.-

Interventions/Control_2

Control food consumption, 5 weeks for efficiency evaluation, within 7 weeks for safety evaluation.--Washout 5 to 12 weeks-Test food consumption, 5 weeks for efficiency evaluation, within 7 weeks for safety evaluation.-

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

49 years-old >=

Gender

Male

Key inclusion criteria

1)Healthy males aged 20 to 49 years old.
2)Subjects whose body mass index (BMI) is 19.0 kg/m2 to 29.9kg/m2
3)Subjects whose visceral fat area is less than 100cm2
4)Subjects who have constant life cycle and custom to go to bed until around 1 a.m.
5)Subjects giving written informed consent.

Key exclusion criteria

1)Subjects who have severe disease in liver, kidney, heart, lung, digestive organ, blood, endocrine system and metabolic system.
2)Subjects who are receiving treatment or medication at the giving point of informed consent.
3)Subjects who have a history of allergic reaction or hypersensitivity to drug medicine and food.
4)Subjects who have a smoking habit.
5)Subjects who drink alcohol a lot.
6)Subjects who have midnight work or irregular shift work.
7)Subjects who cannot stay and lodging in the facility four times.
8)Subjects who are concerned about rashes and itching by attaching electrode pad.
9)Subjects who have no response in power spectrum of heart rate variability after stimulation of autonomic nerve system.
10)Subjects who are participating in the other clinical tests. Subjects who participated within 1 month prior to the current study and/or who plan to participate in the other clinical tests.
11)Subjects who have been judged as unsuitable for the study by the principal investigator or sub-investigator.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takayuki
Middle name
Last name Kodama

Organization

MORISHITA JINTAN CO.,LTD.

Division name

Health Care Product Department

Zip code

540-0004

Address

2-40, Tamatsukuri 1-Chome, Chuo-Ku, Osaka-city, Osaka

TEL

072-800-1044

Email

t-kodama@jintan.co.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Ichinohe

Organization

CPCC Company Limited

Division name

Plan Sales Department

Zip code

101-0047

Address

4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN

TEL

03-5297-3112

Homepage URL


Email

cpcc-contact@cpcc.co.jp


Sponsor or person

Institute

CPCC Company Limited

Institute

Department

Personal name



Funding Source

Organization

MORISHITA JINTAN CO.,LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Chushin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan

Tel

03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 08 Month 17 Day

Date of IRB


Anticipated trial start date

2017 Year 09 Month 07 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 09 Month 04 Day

Last modified on

2020 Year 10 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033163


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name